Induced pluripotent stem (iPS) cell-derived myeloid cells (iPS-ML) that produce the anti-tumor protein interferon-beta (IFN-beta) have been produced and analyzed. Using human iPS-ML in a mouse model, they found that the cells migrate to and deliver IFN-beta to liver tumors thereby reducing cancer proliferation and increasing survival time.